Essex Investment Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-480,918
| Closed | -$10.9M | – | 381 |
|
|
2023
Q1 | $10.9M | Buy |
480,918
+27,601
| +6% | +$627K | 1.59% | 5 |
|
|
2022
Q4 | $10.7M | Buy |
453,317
+16,682
| +4% | +$393K | 1.66% | 5 |
|
|
2022
Q3 | $11.4M | Buy |
436,635
+18,840
| +5% | +$491K | 1.82% | 5 |
|
|
2022
Q2 | $9.17M | Buy |
417,795
+300,550
| +256% | +$6.6M | 1.48% | 6 |
|
|
2022
Q1 | $5.26M | Buy |
117,245
+25,310
| +28% | +$1.14M | 0.66% | 44 |
|
|
2021
Q4 | $3.94M | Sell |
91,935
-3,939
| -4% | -$169K | 0.45% | 60 |
|
|
2021
Q3 | $6.38M | Sell |
95,874
-847
| -0.9% | -$56.3K | 0.78% | 28 |
|
|
2021
Q2 | $7.09M | Buy |
96,721
+49,103
| +103% | +$3.6M | 0.82% | 24 |
|
|
2021
Q1 | $3.26M | Buy |
47,618
+12,576
| +36% | +$861K | 0.4% | 75 |
|
|
2020
Q4 | $2.35M | Sell |
35,042
-5,673
| -14% | -$381K | 0.29% | 108 |
|
|
2020
Q3 | $2.1M | Buy |
40,715
+1,235
| +3% | +$63.5K | 0.3% | 111 |
|
|
2020
Q2 | $1.49M | Buy |
+39,480
| New | +$1.49M | 0.24% | 134 |
|
|
2020
Q1 | – | Sell |
-54,183
| Closed | -$1.86M | – | 405 |
|
|
2019
Q4 | $1.86M | Buy |
54,183
+945
| +2% | +$32.5K | 0.23% | 146 |
|
|
2019
Q3 | $963K | Buy |
+53,238
| New | +$963K | 0.14% | 213 |
|